These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 11551028

  • 1. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A, Kobayashi R, Yoshida M, Kobayashi K, Matsuo K, Kitajima I, Maruyama I.
    Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
    [Abstract] [Full Text] [Related]

  • 2. Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A, Kobayashi R, Kaneda M, Kobayashi K.
    Pediatr Blood Cancer; 2010 Mar; 54(3):437-43. PubMed ID: 19911420
    [Abstract] [Full Text] [Related]

  • 3. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
    Tanikawa S, Mori S, Ohhashi K, Akiyama H, Sasaki T, Kaku H, Hiruma K, Matsunaga T, Morita T, Sakamaki H.
    Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
    [Abstract] [Full Text] [Related]

  • 4. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
    Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G, Strugo L, Destro R, Gazzola MV, Varotto S, Errigo G, Carli M, Zanesco L, Messina C.
    Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
    Pihusch V, Pihusch M, Penovici M, Kolb HJ, Hiller E, Pihusch R.
    Thromb Res; 2005 Oct; 116(3):233-40. PubMed ID: 15935832
    [Abstract] [Full Text] [Related]

  • 6. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years.
    Kalayoglu-Besisik S, Yenerel MN, Caliskan Y, Ozturk S, Besisik F, Sargin D.
    Transplant Proc; 2005 Jun; 37(5):2285-9. PubMed ID: 15964400
    [Abstract] [Full Text] [Related]

  • 7. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.
    Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR.
    Bone Marrow Transplant; 1999 Oct; 24(8):891-5. PubMed ID: 10516702
    [Abstract] [Full Text] [Related]

  • 8. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
    Bazarbachi A, Scrobohaci ML, Gisselbrecht C, Marolleau JP, Mansi A, Brice P, Gorra P, Drouet L.
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
    [Abstract] [Full Text] [Related]

  • 9. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
    Moscardó F, Sanz GF, de La Rubia J, Jiménez C, Saavedra S, Regadera A, Andreu R, García I, Plumé G, Martínez J, Martín G, Jarque I, Sanz MA.
    Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
    [Abstract] [Full Text] [Related]

  • 10. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Oct; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 12. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
    Luzzatto G, Cella G, Messina C, Randi ML, Sbarai A, Zanesco L.
    Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
    [Abstract] [Full Text] [Related]

  • 13. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment.
    Ho V, Momtaz P, Didas C, Wadleigh M, Richardson P.
    Rev Clin Exp Hematol; 2004 Jun 01; 8(1):E3. PubMed ID: 16029969
    [Abstract] [Full Text] [Related]

  • 14. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
    Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Andreesen R, Kolb HJ, Holler E, Pihusch R.
    Bone Marrow Transplant; 2005 Oct 01; 36(7):631-7. PubMed ID: 16062176
    [Abstract] [Full Text] [Related]

  • 15. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M, Ringdén O.
    Transplantation; 1995 Dec 15; 60(11):1293-9. PubMed ID: 8525524
    [Abstract] [Full Text] [Related]

  • 16. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST.
    Cancer Res; 2003 Jun 15; 63(12):3121-6. PubMed ID: 12810638
    [Abstract] [Full Text] [Related]

  • 17. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 18. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation.
    Cheuk DK, Wang P, Lee TL, Chiang AK, Ha SY, Lau YL, Chan GC.
    Bone Marrow Transplant; 2007 Nov 15; 40(10):935-44. PubMed ID: 17768390
    [Abstract] [Full Text] [Related]

  • 19. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
    McDonnell CO, Harmey JH, Bouchier-Hayes DJ, Walsh TN.
    Br J Surg; 2001 Aug 15; 88(8):1105-9. PubMed ID: 11488797
    [Abstract] [Full Text] [Related]

  • 20. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan 15; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.